kyotorphin has been researched along with 5,7-dichlorokynurenic acid in 1 studies
| Studies (kyotorphin) | Trials (kyotorphin) | Recent Studies (post-2010) (kyotorphin) | Studies (5,7-dichlorokynurenic acid) | Trials (5,7-dichlorokynurenic acid) | Recent Studies (post-2010) (5,7-dichlorokynurenic acid) |
|---|---|---|---|---|---|
| 168 | 0 | 22 | 149 | 0 | 18 |
| Protein | Taxonomy | kyotorphin (IC50) | 5,7-dichlorokynurenic acid (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.2828 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.1547 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.1547 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.1547 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.1547 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.1547 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.1547 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Audus, KL; Hirano, K; Hirose, F; Kupczyk-Subotkowska, L; Ryu, T; Sakaeda, T; Siahaan, TJ; Stella, VJ; Sugawara, T; Tada, Y; Yoshikawa, T | 1 |
1 other study(ies) available for kyotorphin and 5,7-dichlorokynurenic acid
| Article | Year |
|---|---|
Conjugation with L-Glutamate for in vivo brain drug delivery.
Topics: Animals; Antineoplastic Agents, Alkylating; Blood-Brain Barrier; Brain; Capillary Permeability; Drug Delivery Systems; Drug Evaluation; Endorphins; Glutamic Acid; Kynurenic Acid; Male; Melphalan; Phenylalanine; Prodrugs; Rats; Rats, Wistar | 2001 |